Upload
reynold-walters
View
212
Download
0
Embed Size (px)
Citation preview
What did genetics say
Ras (-) Signaling eliminated
GAP(-) Signaling increased
Q: Can GAP be the effector of Ras?
A: Yes
B: No
C: not sure
The end of 1992: GAP was no longer considered a Ras effector
The Story of RafCell 1989 Aug:Deborah K. Morrison, David R. Kaplan, Jaime A. Escobedo, Ulf R. Rapp, Thomas M. Roberts and Lewis T. Williams: Direct activation of the serine/threonine kinase activity of raf-1 through tyrosine phosphorylation by the PDGF receptor We have examined the interaction between the serine/threonine kinase proto-oncogene product Raf-1 and the tyrosine kinase PDGF beta-receptor. Raf-1 tyrosine phosphorylation and kinase activity were increased by PDGF treatment of 3T3 cells or CHO cells expressing wild-type PDGF receptors but not mutant receptors defective in transmitting mitogenic signals, suggesting that the increase in Raf-1 kinase activity is a significant event in PDGF-induced mitogenesis. Concurrent with these increases, Raf-1 associated with the ligand-activated PDGF receptor. Furthermore, both mammalian Raf-1 and Raf-1 expressed using a recombinant baculoviral vector, associated in vitro with baculoviral-expressed PDGF receptor. This association was markedly decreased by prior phosphatase treatment of the receptor. Following incubation of partially purified baculoviral-expressed PDGF receptor with partially purified Raf-1, Raf-1 became phosphorylated on tyrosine and its serine/threonine kinase activity increased 4- to 6-fold. This is the first demonstration of the direct modulation of a protein activity by a growth factor receptor tyrosine kinase.
The Story of Raf
Cell 1989 Aug:Deborah K. Morrison, David R. Kaplan, Jaime A. Escobedo, Ulf R. Rapp, Thomas M. Roberts and Lewis T. Williams: Direct activation of the serine/threonine kinase activity of raf-1 through tyrosine phosphorylation by the PDGF receptor
PDGFR
Y-PRaf-1 Raf-1P-
Is this model convincing?A: There is no convincing data to support it. B: The data is good, the proposal is reasonable.
The Story of Raf: summer 1993
Moodie SA, Willumsen BM, Weber MJ, Wolfman A. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase.Science. 1993 Jun
Warne PH, Viciana PR, Downward J. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature. 1993 Jul
Zhang XF,……, Rapp UR, Avruch J. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature. 1993 Jul
Vojtek AB, Hollenberg SM, Cooper JA. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell. 1993 Jul *****
Hughes DA, Ashworth A, Marshall CJ. Complementation of byr1 in fission yeast by mammalian MAP kinase kinase requires coexpression of Raf kinase. Nature. 1993 Jul.
Van Aelst L, Barr M, Marcus S, Polverino A, Wigler M. Complex formation between RAS and RAF and other protein kinases. PNAS. 1993 Jul
Raf had been around for a long time, why did everyone all of a sudden think it is the Ras effector?
Main data in these six papers
1. Raf directly binds to Ras effector domain
2. Oncogenic Ras still interacts with Raf for the function
3. Ras effector domain mutations disrupt binding to Raf
4. Raf’s ability to bind Ras correlates to its function
However, all above are also true for GAP.
Why? What was missing?
Vote: A: Convincing, B: Not convincing
Late 1992 and early 1993
Han M, Golden A, Han Y, Sternberg PW. C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation. Nature. 1993 May
Dickson B, Sprenger F, Morrison D, Hafen E. Raf functions downstream of Ras1 in the Sevenless signal transduction pathway. Nature. 1992 Dec
Ras (gf) Signaling increases (constitutive)
Raf(lf) Signaling eliminates
Ras (lf) Signaling eliminates
Ras (gf); Raf(lf) Signaling eliminates
Ras Raf
Compare Raf with GAP
Ras (lf) Signal eliminatedRaf (lf) Signal eliminatedGAP (lf) Signal increases
Raf(lf) suppress activated Ras
Ras(lf) suppress GAP(lf)
RASGDP
GAP
RASGTP
SOS
GRB2EGFR
Mammalian cells: Ras directly binds to Raf
RAF
Genetic interaction and interpretation of genetic interactions
- Biosynthetic pathway/ genes acting in different steps.
-Order genes in a genetic pathway - studies on yeast mating -pheromone response
- Epistasis analysis using null mutations- The GAP story
- Epistasis analysis using gf mutations - The Ras suppressors
-Enhancer and synergistic effect between two alleles - -The Ras pathway.
-Understanding at molecular level/biochemical level. -Limitation of genetics
Can we learn from double mutants with two mutations with similar phenotypes?
My answer: sometimes the information is extremely important
A: Yes. B: No.
Enhancer effect and synergistic effect
What are the biological base for such effects?
What can we learn from such effects?
How can we use such effects to identify genes?
How do we design screens to deal with the problem of genetic redundancy (see next lecture)
Interaction between null or severe lf alleles
Function
OnOffOff
OffOnOff
Gene A Gene BLack the functionLack the functionLack the function, same as above
Linear relationship
Function
OnOffOff
OffOnOff
Gene A
Gene BLack part of the function, weak phenotypeLack part of the function, weak phenotypeLack both, strong phenotype
parallel relationship
Interaction between partial lf alleles
Function
OnReducedReduced
ReducedOnReduced
Gene A Gene BFunction compromised, weak phenotypeFunction compromised, weak phenotypeLack the function, strong phenotype.
Function
OnReducedReduced
ReducedOnReduced
Gene A
Gene BPart of the function reducedPart of the function reducedBoth reduced, stronger phenotype
Linear relationship
parallel relationship
Big time example: dauer formaton
Dauer formation
On
Off
Off
Off
On
Off
daf-11daf-21
Constitutive Dauer at 25°C
Constitutive Dauer at 25°C
100% dauer at all temperature
daf-7 daf-1daf-4
daf-8daf-14
Pathway ATGF signaling
Pathway B
Pathway A Pathway B phenotype
Non-allelic noncomplementation
QuickTime™ and aPhoto - JPEG decompressor
are needed to see this picture.
Synergistic effect of reducing gene activity in two genes in the same pathwaySeeing dominant effect in recessive mutations
Hartwell et alGenetics
Modifior screen 1
Enhancer screen
Simon and Rubin, 1991, Cell
Drosophila: F1 screen vs F2 screen
X
* *X
**
F3 homozygotes
mutagen
X
TM
TM
*
*F1
F2 screen mutagen
X*
*F1
F1 screen
TM
A conversation with Rubin
Mike Simon : landmark modify screenSimon et al. 1991 Cell
Sev RAS SOS R7
Rough eye, no R7
Mostly wt, small % defects
Rough eye
Rough eye
Rough eye
High T
Low T
Low T
Low T
Low T
Ts allele
X*
*F1
F1 screen
TM
+/-
+/-
b. Reducing activities in two genes acting in parallel pathways
Question: If both Sev and Ras were knockout in R7 cells, would you see a severer phenotype in R7 than that in flies with either gene knocked out?
Sev Ras
Question: What if I ask the same question about two genes acting in parallel pathways?
A
Bfunction
1. Interaction between two null allelesNo enhancement: likely linear relationshipDrastic enhancement: likely parallel
Summary:
2. Interaction between two partial loss-of function alleles Genes in the same pathway more likely to have drastic enhancement Genes in parallel pathway may have some effects
Modifior screen 2
suppressor screen
SUR-6 KSR-1SUR-8 SUR-7
SUR-5 SUR-4 SUR-9
Ras X vulvalfunctions
gf Multivulva
Vulvaless
WT
Suppressor of ras mutations define regulators
1
WT2
Y
sup
RAS MPKMEKRAF TFs
SUR-6
KSR-1
SUR-8
SUR-7
SUR-4
SUR-9
RTK RAS MPKMEKGRB2 SOS RAF TFs
Question:
All sur genes may act after Ras since mutations
in these genes suppress activated Ras
SUR-8 & KSR-1 are required for Ras signaling
% v
ulv
al i
nd
uct
ion
100
100 100
ksr(lf)sur-8(lf)
4
sur-8(lf)ksr(lf)
RAS RAF MEKSOS
KSR-1
SUR-8 MPK
Redundant?
SUR-8 and KSR do not have redundant biochem functions
% v
ulv
al i
nd
uct
ion
100
100
mpk-1(rf)Ksr-1(lf) Ksr-1mpk
100
98100
3
RAS RAF MEKSOS
KSR-1
SUR-8 MAPK
98
mpk-1(rf)sur-8(lf) sur-8mpk-1
0
Two separate inputs
Ras Raf
SUR-8
MEK
KSR
MPK
SUR-6PP2A-B
recruiter
pathway
SUR-5 (novel)
SUR-8 acts in a separate pathway from KSR, while SUR-6 and SUR7 may act in the same pathway as KSR
SUR-7
scaffoldd
Double mutants synergistic phenotype?Sur-8(lf) + sur-6/7(lf) yesKsr(lf) + sur-6/7 (lf) no
Vulval differentiation
_ +
InductionRepression
RassynMuv
Multiple regulatory pathway specify vulval differentiation
Vulval differentiation
Class BSynMuv
Class ASynMuvrepression
Wild type
Phenotype
Multivulva
Wild type
Wild type
Class A +Class B +
Class B -Class A +
Genotype
Class A -Class B +
Class B -Class A -
Synthetic Muv phenotype define redundant genetic pathways
synMuv screen
lin-8(-)lin-8(-)
MultivulvaWild type
mutagen
lin-8(-)lin-8(-)
Wild type
;synMuvB(-) +
lin-8(-)lin-8(-)
;synMuvB(-)synMuvB(-)
Vulval induction
lin-8
lin-35
Class A gene
Class B gene
Screen for synthetic lethal mutations by using an extrachromosomal array
gene A (-)gene A (-)
Ex gene A(+) Wild type
mutagen
Po
Wild type
gene A (-)gene A (-)
Ex gene A(+)
gene B (lf) +
;Wild type
Lost the array
F1
gene A (-)gene A (-)
gene A (-)gene A (-)
Ex gene A(+)
gene B (lf)gene B (lf)
; gene A (-)gene A (-)
gene B (lf)gene B (lf)
;
Lost the arrayWith the array
Dead larva or eggs Due to gene A(-) and gene B(lf)
Wild type
F3
N-longer see wild-type progeny that have lost the array
gene A (-)gene A (-)
Ex gene A(+)
gene B (lf)gene B (lf)
;
Wild type
F2
Lost the array
Wild type mutant
Clone individuals
gene A (-)gene A (-)
gene B (lf)gene B (lf)
;
Epistasis with genes in sequential events
Event 1 Event 2 Event 2 product
Gene A
On
Off
Off
Gene B
Off
On
Off
Phenotype
Event 1 product
No event 1
No event 1
Vulval differentiation
Generation of precursor cells
lin-26
On
Off
Off
lin-1
Off
On
Off
Phenotype
Multivulva
No vulva cells
No vulva cells
Induction of vulva fate
Example 1 Vulval development
Example 2. Cell death in C. elegans
Completed cell death
Cell killing
ced-3
On
Off
Off
ced-1
Off
On
Off
Phenotype
Cell corpes persist
Cell lives
Cell lives
Engulfment of killed cells
Mutant
arg 1
arg 2-3
arg 4-7
Grwoth medium
Minimal
-
-
-
Minmal+ Arginine
+
+
+
Minmal+citulline
-
+
+
Minmal+Ornithine
-
-
+
ornithine citulline argininearg 1arg 2-3arg 4-7
Srb and Horowitz, 1944
RTK RAS GRB2 SOS RAF
UNC-101ARK-1 SLI-1(CBL)
GAP-1
Ark-1 Sli-1 Gap-1 Unc-101 Ark-1Sli-1
Ark-1Gap-1
Ark-1Unc-101
0 0 0 0
40
29
90% Multivulva